Esther A. Koop

Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy

Vincent M. T. de Jong, Yuwei Wang, Natalie D. ter Hoeve et al. · Zurich Open Repository and Archive (University of Zurich) · 2022 · 103 citations · Full text

Expression of BNIP3 in invasive breast cancer: correlations with the hypoxic response and clinicopathological features

Esther A. Koop, Theo van Laar, D.F. van Wichen et al. · BMC Cancer · 2009 · 62 citations · Full text

Interobserver Variation in the Assessment of Immunohistochemistry Expression Levels in HER2-Negative Breast Cancer: Can We Improve the Identification of Low Levels of HER2 Expression by Adjusting the Criteria? An International Interobserver Study

Ximena Baez‐Navarro, Mieke Van Bockstal, Diënna Nawawi et al. · Modern Pathology · 2023 · 41 citations · Full text

Breast Oncology, Oncology, Her2 Expression +9

Long-term prognosis of young breast cancer patients (≤40 years) who did not receive adjuvant systemic treatment: protocol for the PARADIGM initiative cohort study

Gwen Dackus, Natalie D. ter Hoeve, Mark Opdam et al. · BMJ Open · 2017 · 40 citations · Full text

Nuclear morphometric features in benign breast tissue and risk of subsequent breast cancer

Yan Cui, Esther A. Koop, P. J. van Diest et al. · Breast Cancer Research and Treatment · 2006 · 30 citations · Full text